0001445305-14-002618.txt : 20140625 0001445305-14-002618.hdr.sgml : 20140625 20140618083832 ACCESSION NUMBER: 0001445305-14-002618 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140617 ITEM INFORMATION: Other Events FILED AS OF DATE: 20140618 DATE AS OF CHANGE: 20140618 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GREATBATCH, INC. CENTRAL INDEX KEY: 0001114483 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690] IRS NUMBER: 161531026 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-16137 FILM NUMBER: 14926764 BUSINESS ADDRESS: STREET 1: 2591 DALLAS PARKWAY, SUITE 101 CITY: FRISCO STATE: TX ZIP: 75034 BUSINESS PHONE: 716-759-5600 MAIL ADDRESS: STREET 1: 2591 DALLAS PARKWAY, SUITE 101 CITY: FRISCO STATE: TX ZIP: 75034 FORMER COMPANY: FORMER CONFORMED NAME: WILSON GREATBATCH TECHNOLOGIES INC DATE OF NAME CHANGE: 20000511 8-K 1 a8-kcemarkapproval.htm 8-K 8-KCEMarkApproval


U.S. SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549




FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): June 17, 2014


GREATBATCH, INC.
(Exact name of registrant as specified in its charter)



Delaware
1-16137
16-1531026
(State or Other Jurisdiction of
incorporation)
(Commission File Number)
(IRS Employer Identification No.)

2595 Dallas Parkway, Suite 310, Frisco, Texas
75034
(Address of principal executive offices)
(Zip Code)

Registrant’s telephone number, including area code (716) 759-5600


 
Not Applicable
 
 
(Former name or former address, if changed since last report)
 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))








Item 8.01.
Other Events.


On June 17, 2014, Greatbatch, Inc. (the "Company") received CE Mark from the designated European Notified Body, TÜV SÜD America for its Algovita (formerly known as Algostim) product. Algovita is a Spinal Cord Stimulation System (SCS) to treat chronic intractable pain of the trunk and/or limbs. The approval reflects another milestone in Greatbatch’s strategic evolution of its product offerings to include the development of complete medical device systems in order to raise the growth and profitability profile of the Company.  This medical device strategy is being facilitated through the Company’s subsidiary, QiG Group, and leverages Greatbatch’s intellectual property and discrete technologies.




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated:
June 18, 2014
GREATBATCH, INC.
 
 
 
 
 
 
 
By:
/s/ Thomas J. Mazza
 
 
 
 
Thomas J. Mazza
 
 
 
 
Vice President and Corporate Controller